Realm Therapeutics PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Realm Therapeutics PLC with three other
companies in this sector in the United Kingdom:
Tissue Regenix Group PLC
sales of £816,000.00 [US$1.06 million]
of which 108%
was Wound Care),
Silence Therapeutics Plc
(£770,000.00 [US$998,705.40 ]
Oxford Pharmascience Group PLC
(£796,000.00 [US$1.03 million]
of which 100%
was Delivery systems).
Sales fell dramatically in 2016:
Realm Therapeutics PLC reported sales of £644,819.07 (US$836.34 thousand)
December of 2016.
decrease of 95.8%
versus 2015, when the company's sales were £15.35 million.